Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113523-113523
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Recent Advances in Pyrimidine-Based Drugs
Baskar Nammalwar, Richard A. Bunce
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 104-104
Open Access | Times Cited: 26
Sulfoxidation of pyrimidine thioate derivatives and study their biological activities
Atif A. El‐Gharably, Amal A. Nassar, N. M. El-Ganzory, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors
Ulviye Acar Çevik, İsmail Çeli̇k, Ayşen Işık, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1944-1958
Closed Access | Times Cited: 60
An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy
Khalid Saad Alharbi, Mohammad Arshad Javed Shaikh, Obaid Afzal, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110108-110108
Closed Access | Times Cited: 40
Synthesis of Novel 2-((3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)hydrazinyl-4-phenylthiazole: Potent EGFR Targeting Anticancer Agents
Sateesh Amudala, Rambabu Palabindela, Srinu Bhoomandla, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 1, pp. 34-44
Closed Access | Times Cited: 6
One-Pot quaternization strategy for novel Poly(pyridinium-acetamide) ionic polymers as potential anticancer and anti-microbial agents
Salsabeel Al-Sodies, Mahmoud A. Hussein, Abdullah M. Asiri, et al.
European Polymer Journal (2025), pp. 113729-113729
Closed Access
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 34
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)
Lian‐Shun Feng, Wen‐Qi Su, Jin‐Bo Cheng, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 34
In-situ detection scheme for EGFR gene with temperature and pH compensation using a triple-channel optical fiber biosensor
Xuegang Li, Pengqi Gong, Xue Zhou, et al.
Analytica Chimica Acta (2023) Vol. 1263, pp. 341286-341286
Closed Access | Times Cited: 19
Novel pyrimidines as COX-2 selective inhibitors: synthesis, DFT analysis, molecular docking and dynamic simulation studies
Basavarajaiah Suliphuldevara Mathada, N. Jeelan Basha, Mohammad Javeed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1751-1764
Closed Access | Times Cited: 19
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188927-188927
Closed Access | Times Cited: 19
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9795-9811
Closed Access | Times Cited: 14
Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M. Ibrahim, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1087-1107
Closed Access | Times Cited: 5
Recent advances in the development of EGFR degraders: PROTACs and LYTACs
Dawei Hong, Bizhong Zhou, Bei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114533-114533
Closed Access | Times Cited: 25
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Mu‐Chun Li, Mohane Selvaraj Coumar, Shu‐Yu Lin, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2566-2588
Open Access | Times Cited: 10
Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
Mingtao Zhu, Yanping Sun, Haodong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines
Ghada Mohamed Safwat, Kamel M. A. Hassanin, Eman T. Mohammed, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 22
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies
Zaman Hasanvand, Tayebeh Oghabi Bakhshaiesh, Fariba Peytam, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106383-106383
Closed Access | Times Cited: 8
Design, synthesis, and biological activity evaluation of novel tubulin polymerization inhibitors based on pyrimidine ring skeletons
Yingying Kang, Yuanyuan Pei, Jinling Qin, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 84, pp. 129195-129195
Closed Access | Times Cited: 8
Organocatalytic [3 + 2] Cycloaddition Reaction: Synthesis of Fully Decorated Sulfonyl-1,2,3-Triazolyl Pyrimidines as Potent Anticancer and EGFR Inhibitors
Jagan Mohan Reddy Velidandla, Shiva Kumar Koppula
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 4, pp. 2675-2687
Closed Access | Times Cited: 8
Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery
Iashia Tur Razia, Ayesha Kanwal, Hafiza Fatima Riaz, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 30, pp. 2844-2862
Closed Access | Times Cited: 8
The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids
Peng Zhang, Congcong Shi, Tongbao Dong, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 905-924
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top